ClinicalTrials.gov
ClinicalTrials.gov Menu

Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung Clinics

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00268866
Recruitment Status : Completed
First Posted : December 23, 2005
Last Update Posted : April 16, 2008
Sponsor:
Information provided by:
Boehringer Ingelheim

Brief Summary:
Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics

Condition or disease Intervention/treatment
Pulmonary Disease, Chronic Obstructive Behavioral: Education

Detailed Description:

Study Hypothesis:

Comparison(s):


Study Type : Observational
Enrollment : 1820 participants
Official Title: Danish Quality Assurance Project on Diagnosis and Treatment of COPD in Outpatient Lung Clinics
Study Completion Date : January 2007

Resource links provided by the National Library of Medicine

MedlinePlus related topics: COPD




Primary Outcome Measures :
  1. To optimise the diagnosis and treatment of COPD via a quality assurance project
  2. Increase the knowledge and use of diagnostic tools and treatment options
  3. Increase focus on COPD comorbidity


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   35 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Outpatient with the diagnosis or referral diagnosis of COPD.
  • COPD must be the primary reason for this outpatient contact (for both new patients and controls).

Exclusion Criteria:

  • Any co-morbidity that hampers the diagnosis and treatment of COPD in accordance with the COPD guidelines used locally (e.g. malignant disease, dementia or sequelae of apoplexy).
  • Asthma without the presence of COPD

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00268866


Sponsors and Collaborators
Boehringer Ingelheim
Investigators
Study Chair: Boehringer Ingelheim Study Coordinator B.I. Denmark A/S

ClinicalTrials.gov Identifier: NCT00268866     History of Changes
Other Study ID Numbers: 205.367
First Posted: December 23, 2005    Key Record Dates
Last Update Posted: April 16, 2008
Last Verified: April 2008

Additional relevant MeSH terms:
Lung Diseases
Pulmonary Disease, Chronic Obstructive
Chronic Disease
Respiratory Tract Diseases
Lung Diseases, Obstructive
Disease Attributes
Pathologic Processes